Background And Objectives: Drug addiction is a serious illness with deleterious functional and social consequences for both the affected individuals, their families, and society at large. In spite of the abundant research on substance dependence, there are few effective treatments for this disease. Given the crucial role of the endogenous opioid system in the development and maintenance of substance abuse disorders, this review focuses on the opioidergic system and examines the role of opioidergic genes in the treatment outcome of pharmacotherapies of alcohol, opioid, and cocaine addiction.
Methods: Scopus (all databases) and Pubmed were systematically searched with no language or year restrictions, up to July 2014, for studies that focused on the relationship between polymorphisms of opioidergic genes and the treatment outcome of pharmacotherapies of alcohol, opioid, and cocaine addictions. Selected search terms were opioid, gene, polymorphism, drug therapy, substance abuse, and response.
Results And Conclusions: The genetic variability of μ-, δ- and κ-opioid receptors genes OPRM1, OPRD1, and OPRK1 modulates the efficacy of opioid antagonist treatments such as naltrexone and methadone, as well as the cocaine vaccine. Despite the number of promising reports, data from additional cohorts are needed to substantiate these findings.
Scientific Significance: Gene variant profiling could help predict treatment response and assist in developing effective treatments for alcohol, opioid, and cocaine addiction.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ajad.12172 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Peroxisome proliferator-activated receptor gamma: A promising therapeutic target for the treatment of chronic pain.
Brain Res
November 2024
Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China. Electronic address:
Article Synopsis
- * PPARγ, a nuclear receptor involved in metabolism, plays a role in regulating genes linked to inflammation and pain relief, with reduced levels found in areas related to chronic pain in animal studies.
- * Evidence suggests that activating PPARγ with natural or synthetic agonists can help alleviate chronic pain by reducing inflammation and oxidative stress, making it a promising area for further research.
Differential methylation of OPRK1 in borderline personality disorder is associated with childhood trauma.
Mol Psychiatry
December 2024
Department of Psychosomatic Medicine and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
According to a growing body of neurobiological evidence, the core symptoms of borderline personality disorder (BPD) may be linked to an opioidergic imbalance between the hedonic and stimulatory activity of mu opioid receptors (MOR) and the reward system inhibiting effects of kappa opioid receptors (KOR). Childhood trauma (CT), which is etiologically relevant to BPD, is also likely to lead to epigenetic and neurobiological adaptations by extensive activation of the stress and endogenous opioid systems. In this study, we investigated the methylation differences in the promoter of the KOR gene (OPRK1) in subjects with BPD (N = 47) and healthy controls (N = 48).
View Article and Find Full Text PDFHuman OPRM1 and murine Oprm1 promoter driven viral constructs for genetic access to μ-opioidergic cell types.
Nat Commun
September 2023
Dept. of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
With concurrent global epidemics of chronic pain and opioid use disorders, there is a critical need to identify, target and manipulate specific cell populations expressing the mu-opioid receptor (MOR). However, available tools and transgenic models for gaining long-term genetic access to MOR+ neural cell types and circuits involved in modulating pain, analgesia and addiction across species are limited. To address this, we developed a catalog of MOR promoter (MORp) based constructs packaged into adeno-associated viral vectors that drive transgene expression in MOR+ cells.
View Article and Find Full Text PDFThe effect of acetic acid-induced pain in Parkinson's disease model in zebrafish.
Neurotoxicology
December 2023
Department of Biochemistry, Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey.
Parkinson's disease (PD) is the second most common neurodegenerative disease caused by the degeneration of dopaminergic neurons and the accumulation of Lewy bodies. Pain is one of the most common non-motor symptoms in PD, but the molecular mechanism of pain in PD is not fully understood, which prevents early diagnosis of PD. We aimed to determine the changes in opioidergic pathways when external pain is inflicted by inducing pain intraperitoneally in zebrafish, for which we generated a rotenone-induced PD model.
View Article and Find Full Text PDFGenetic variants associated with post-traumatic stress symptoms in patients with gynecologic cancer.
Gynecol Oncol
March 2023
University of Minnesota, Department of Obstetrics, Gynecology and Women's Health, Minneapolis, MN, United States of America. Electronic address:
Article Synopsis
- Patients with gynecologic cancer show higher rates of PTSD symptoms than the general population, prompting a study to explore genetic factors related to this risk.
- Researchers recruited 181 survivors and analyzed saliva samples for SNPs linked to PTSD, finding that two specific SNPs (rs622337 in HTR2A and rs510769 in OPRM1) were significantly associated with increased PTSD scores.
- The study suggests that genetic variations, particularly in serotonin and opioid receptor pathways, may contribute to PTSD development in cancer patients, providing insights for healthcare providers to better support at-risk individuals.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!